{
  "Q0": "BRCA1/2 testing",
  "Q1": "Yes",
  "Q2": "Not specified",
  "Q3": "No",
  "Q4": "Yes",
  "Q4_followup": {
    "guideline_match": "No",
    "guidelines": "NCCN"
  },
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8_followup": {
    "alternative_test": "Multigene panel testing for moderate to high-penetrance breast and/or epithelial ovarian cancer susceptibility genes"
  },
  "Q9": "Yes",
  "Q9_followup": {
    "family_history_match": "No"
  },
  "Q10": "No",
  "Q10_followup": [
    "Risk Assessment"
  ],
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Yes",
  "Q14_followup": {
    "CPT_code": "81162"
  },
  "Q15": "No",
  "Q16": "No",
  "Q17": "The provider must complete the Aetna Breast and Ovarian Cancer Susceptibility Gene Prior Authorization Form, confirming the basis for high-risk status, and submit it along with the Laboratory's test requisition form. The test should not be performed until confirmation of coverage is received and the test is precertified.",
  "match": true
}